ONCOLYTICS BIOTECH INC. Number Of Share Options Exercisable In Share-based Payment Arrangement
ONCOLYTICS BIOTECH INC. (ONCY) had Number Of Share Options Exercisable In Share-based Payment Arrangement of 4.72 million shares as of 2024-12-31, per its 20-F filed 2025-03-07.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement · last filed 2025-03-07
- 2018-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 77724500.00%.
- 2017-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 545350100.00%.
pure
| Period end | Number Of Share Options Exercisable In Share-based Payment Arrangement |
|---|---|
| 2018-12-31 | 77724500.00% 20-F · filed 2019-03-15 |
| 2017-12-31 | 545350100.00% 20-F · filed 2018-03-19 |
shares
| Period end | Number Of Share Options Exercisable In Share-based Payment Arrangement | Number Of Share Options Exercisable In Share-based Payment Arrangement as first filed |
|---|---|---|
| 2024-12-31 | 4.72M shares 20-F · filed 2025-03-07 | |
| 2023-12-31 | 5.04M shares 20-F · filed 2025-03-07 | |
| 2022-12-31 | 4.42M shares 20-F · filed 2025-03-07 | |
| 2021-12-31 | 3.17M shares 20-F · filed 2024-03-12 | |
| 2020-12-31 | 2.16M shares 20-F · filed 2023-03-03 | |
| 2019-12-31 | 1.33M shares 20-F · filed 2022-03-03 | |
| 2018-12-31 | 777.25K shares 20-F · filed 2021-03-05 | |
| 2017-12-31 | 573.98K shares 20-F · filed 2020-03-06 | 5.45M shares 20-F · filed 2018-03-19 |
| 2016-12-31 | 689.88K shares 20-F · filed 2019-03-15 | 6.73M shares 20-F · filed 2018-03-19 |
| 2015-12-31 | 6.48M shares 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |